These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 27027879)
21. Conformational ensembles, signal transduction and residue hot spots: application to drug discovery. Acuner Ozbabacan SE; Gursoy A; Keskin O; Nussinov R Curr Opin Drug Discov Devel; 2010 Sep; 13(5):527-37. PubMed ID: 20812144 [TBL] [Abstract][Full Text] [Related]
25. Systematic analysis of helical protein interfaces reveals targets for synthetic inhibitors. Jochim AL; Arora PS ACS Chem Biol; 2010 Oct; 5(10):919-23. PubMed ID: 20712375 [TBL] [Abstract][Full Text] [Related]
26. How well can fragments explore accessed chemical space? A case study from heat shock protein 90. Roughley SD; Hubbard RE J Med Chem; 2011 Jun; 54(12):3989-4005. PubMed ID: 21561141 [No Abstract] [Full Text] [Related]
27. The Elements of Translational Chemical Biology. Copeland RA; Boriack-Sjodin PA Cell Chem Biol; 2018 Feb; 25(2):128-134. PubMed ID: 29233521 [TBL] [Abstract][Full Text] [Related]
29. Protein binding site analysis for drug discovery using a computational fragment-based method. Ludington JL Methods Mol Biol; 2015; 1289():145-54. PubMed ID: 25709039 [TBL] [Abstract][Full Text] [Related]
30. Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists. Våbenø J; Haug BE; Rosenkilde MM Future Med Chem; 2015; 7(10):1261-83. PubMed ID: 26144264 [TBL] [Abstract][Full Text] [Related]
31. Halogen-enriched fragment libraries as chemical probes for harnessing halogen bonding in fragment-based lead discovery. Zimmermann MO; Lange A; Wilcken R; Cieslik MB; Exner TE; Joerger AC; Koch P; Boeckler FM Future Med Chem; 2014 Apr; 6(6):617-39. PubMed ID: 24895892 [TBL] [Abstract][Full Text] [Related]
32. Targeting protein-protein interactions for therapeutic intervention: a challenge for the future. Zinzalla G; Thurston DE Future Med Chem; 2009 Apr; 1(1):65-93. PubMed ID: 21426071 [TBL] [Abstract][Full Text] [Related]
33. [Study of protein ligand variety based on database analyses]. Shirai T Seikagaku; 2013 Aug; 85(8):671-8. PubMed ID: 24050010 [No Abstract] [Full Text] [Related]
34. "Pharmacoperone": what's in a word? Conn PM; Ulloa-Aguirre A; Janovick JA Pharmacol Res; 2014 May; 83():1-2. PubMed ID: 24269962 [No Abstract] [Full Text] [Related]
35. Modulating protein-protein interactions: the potential of peptides. Nevola L; Giralt E Chem Commun (Camb); 2015 Feb; 51(16):3302-15. PubMed ID: 25578807 [TBL] [Abstract][Full Text] [Related]
37. Chemical informatics: using molecular shape descriptors in structure-based drug design. Jennings A Methods Mol Biol; 2012; 841():235-50. PubMed ID: 22222455 [TBL] [Abstract][Full Text] [Related]
38. Drug effect prediction by polypharmacology-based interaction profiling. Simon Z; Peragovics A; Vigh-Smeller M; Csukly G; Tombor L; Yang Z; Zahoránszky-Kohalmi G; Végner L; Jelinek B; Hári P; Hetényi C; Bitter I; Czobor P; Málnási-Csizmadia A J Chem Inf Model; 2012 Jan; 52(1):134-45. PubMed ID: 22098080 [TBL] [Abstract][Full Text] [Related]
39. Importance of Rigidity in Designing Small Molecule Drugs To Tackle Protein-Protein Interactions (PPIs) through Stabilization of Desired Conformers. Lawson ADG; MacCoss M; Heer JP J Med Chem; 2018 May; 61(10):4283-4289. PubMed ID: 29140691 [TBL] [Abstract][Full Text] [Related]
40. Targeted Small-Molecule Conjugates: The Future is Now. Dal Corso A Chembiochem; 2020 Dec; 21(23):3321-3322. PubMed ID: 32893949 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]